Lund
Sweden
70
2026-05-28
The entities that hold a legal rights for patent applications filed by inventor TIBERG Fredrik:
Fredrik TIBERG from Lund, SE has applied for patents for these inventions. The list has both pending applications and granted patents:
COMPOSITIONS AND METHODS FOR TREATING ACROMEGALY
#2 | 2026-04-09OPIOID FORMULATIONS
#3 | 2026-01-01SOMATOSTATIN RECEPTOR AGONIST FORMULATIONS
#4 | 2025-10-23LIPID-CONTROLLED RELEASE COMPOSITIONS
#5 | 2025-10-16PROSTACYCLIN ANALOGUE FORMULATIONS
#6 | 2025-09-11COMPOSITIONS AND METHODS FOR TREATING NEUROENDOCRINE TUMORS
#7 | 2025-09-11LIPID DEPOT FORMULATIONS
#8 | 2025-04-17CONTROLLED RELEASE PEPTIDE FORMULATIONS
#9 | 2025-02-13Opioid formulations
#10 | 2025-02-06INJECTABLE BUPRENORPHINE FORMULATION
#11 | 2025-01-02PEPTIDE SLOW-RELEASE FORMULATIONS
#12 | 2024-07-11OPIOID FORMULATIONS
#13 | 2024-04-25OPIOID FORMULATIONS
#14 | 2024-03-07Opioid formulations
#15 | 2023-11-23SOMATOSTATIN RECEPTOR AGONIST FORMULATIONS
#16 | 2023-01-26LIPID DEPOT FORMULATIONS
#17 | 2022-12-08PROSTACYCLIN ANALOGUE FORMULATIONS
#18 | 2022-09-15FORMULATIONS AND TREATMENT METHODS
#19 | 2022-06-30Lipid-controlled release compositions
#20 | 2021-10-07CONTROLLED RELEASE PEPTIDE FORMULATIONS
#21 | 2021-10-07Injectable buprenorphine formulation
#22 | 2021-09-02PEPTIDE SLOW-RELEASE FORMULATIONS
#23 | 2021-06-17Opioid formulations
#24 | 2021-05-13Opioid formulations
#25 | 2021-05-06LIPID DEPOT FORMULATIONS
#26 | 2020-12-03OPIOID FORMULATIONS
#27 | 2020-11-12CONTROLLED-RELEASE FORMULATIONS
#28 | 2020-11-05Opioid formulations
#29 | 2019-11-21LIPID FORMULATIONS COMPRISING A THIOLATED ANTIOXIDANT
#30 | 2019-08-22Prostacyclin analogue formulations
#31 | 2019-02-21PEPTIDE SLOW-RELEASE FORMULATIONS
#32 | 2018-11-01LIPID DEPOT FORMULATIONS
#33 | 2018-09-13CONTROLLED-RELEASE FORMULATIONS
#34 | 2018-09-06OPIOID FORMULATIONS
#35 | 2018-07-26ACID CONTAINING LIPID FORMULATIONS
#36 | 2018-03-22GNRH ANALOGUE FORMULATIONS
#37 | 2018-01-18INJECTABLE BUPRENORPHINE FORMULATION
#38 | 2018-01-04CONTROLLED-RELEASE FORMULATIONS
#39 | 2017-10-05LIPID FORMULATIONS COMPRISING A THIOLATED ANTIOXIDANT
#40 | 2015-12-24PEPTIDE SLOW-RELEASE FORMULATIONS
#41 | 2015-12-24Pharmaceutical lipid compositions
#42 | 2015-07-02Opioid formulations
#43 | 2015-05-28Topical bioadhesive formulations
#44 | 2015-04-16Somatostatin receptor agonist formulations
#45 | 2015-03-05LIPID DEPOT FORMULATIONS
#46 | 2014-11-27Robust controlled-release formulations
#47 | 2014-11-06Robust controlled-release peptide formulations
#48 | 2014-08-07TOPICAL BIOADHESIVE FORMULATIONS
#49 | 2014-07-10LIPID DEPOT FORMULATIONS
#50 | 2014-07-03Topical bioadhesive formulations
#51 | 2014-06-12Controlled release peptide formulations
#52 | 2013-07-25HIGH BIOAVAILABILITY OPIOID FORMULATIONS
#53 | 2012-10-25Lipid depot formulations
#54 | 2012-02-02Acid containing lipid formulations
#55 | 2011-09-22Lipid formulations comprising a thiolated antioxidant
#56 | 2010-08-19Peptide slow-release formulations
#57 | 2009-07-02GnRH analogue formulations
#58 | 2009-06-18Topical bioadhesive formulations
#59 | 2009-03-12Somatostatin analogue formulations
#60 | 2008-11-06Pharmaceutical lipid compositions
#61 | 2008-08-28Ternary non-lamellar lipid compositions
#62 | 2008-07-03Compositions forming non-lamellar dispersions
#63 | 2008-06-19Glp-1 analogue formulations
#64 | 2008-05-29Controlled-release formulations
#65 | 2008-04-10Liquid depot formulations
#66 | 2007-12-06Non-lamellar compositions of DOPE and P80
#67 | 2007-11-15Opioid depot formulations
#68 | 2007-10-04Composition Comprising Ether Lipid
#69 | 2007-06-14Method for improving the properties of amphiphile particles
#70 | 2007-05-17Method for loading amphiphile particles with active agents
355686 ⎘